![Henry E. Schea](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Henry E. Schea
Presidente en Genopoietic SA .
Cargos activos de Henry E. Schea
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Genopoietic SA
![]() Genopoietic SA BiotechnologyHealth Technology Part of AVAX Technologies, Inc., Genopoietic SA is a French company that researches and develops cell and gene therapy for cancer, autoimmune diseases, and orthopedics. The company is based in Paris, France. Genopoietic was acquired by AVAX Technologies, Inc. on August 24, 2000 for $198.62 million. | Presidente | 21/10/2011 | - |
Historial de carrera de Henry E. Schea
Antiguos cargos conocidos de Henry E. Schea.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
AVAX TECHNOLOGIES, INC. | Consejero General | 04/01/2010 | 01/04/2016 |
Formación de Henry E. Schea.
University of Massachusetts | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 3 |
Francia | 2 |
Operativa
General Counsel | 1 |
President | 1 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
AVAX TECHNOLOGIES, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Genopoietic SA
![]() Genopoietic SA BiotechnologyHealth Technology Part of AVAX Technologies, Inc., Genopoietic SA is a French company that researches and develops cell and gene therapy for cancer, autoimmune diseases, and orthopedics. The company is based in Paris, France. Genopoietic was acquired by AVAX Technologies, Inc. on August 24, 2000 for $198.62 million. | Health Technology |
- Bolsa de valores
- Insiders
- Henry E. Schea
- Experiencia